Sagent Pharmaceuticals, Inc.·4

Mar 26, 4:08 PM ET

Sagent Pharmaceuticals, Inc. 4

4 · Sagent Pharmaceuticals, Inc. · Filed Mar 26, 2013

Insider Transaction Report

Form 4
Period: 2013-03-25
Transactions
  • Award

    Stock Option to Buy

    2013-03-25+100,000100,000 total
    Exercise: $17.29Exp: 2023-03-25Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The option vests in four equal installments beginning on March 25, 2014.

Documents

1 file
  • 4
    rrd375080.xmlPrimary